DCF — SIERRA VIEW MEDICAL CENTER
Enterprise Value: $-396.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-396.2M
Enterprise Value
$-122.1M
PV of Cash Flows
$-274.1M
PV of Terminal Value
$-441.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $150.5M | $-26.5M | -18.0% | $-32.8M | $-29.9M |
| Year 2 | $155.0M | $-25.7M | -17.0% | $-32.3M | $-26.7M |
| Year 3 | $159.6M | $-24.9M | -16.0% | $-31.6M | $-23.8M |
| Year 4 | $164.4M | $-24.8M | -15.0% | $-31.8M | $-21.7M |
| Year 5 | $169.3M | $-25.1M | -15.0% | $-32.3M | $-20.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-396.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$146.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.18091870542367233
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5